ROCHE FINANCE LTD - 31 Dec 2024 SCHEDULE 13G/A Report for Entrada Therapeutics, Inc. Common Stock, $0.0001 par value per share (TRDA)

Filing Manager: ROCHE FINANCE LTD
Reporting Manager: Roche Finance Ltd
Security: Entrada Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol: TRDA
Shares outstanding: 37,233,551 shares
Disclosed Ownership: 2,569,115 shares
Ownership: 6.9%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 15:47:55 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Roche Finance Ltd	6.9%	2,569,115	0	2,569,115	/s/ Carole Nuechterlein	Carole Nuechterlein, Authorized Signatory
Roche Holding Ltd	6.9%	2,569,115	0	2,569,115	/s/ Peter Trybus	Peter Trybus, Authorized Signatory